Delisting risk
Xtant Medical
Supplies orthobiologics, spine implants, and U.S. surgical-hemostasis products.
$0.3700
After-hours close−0.04 (−8.78%)
At close$0.4056(+22.91%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 57.22%80.25M sharesInsiders 11.33%15.89M sharesOther 31.45%44.13M shares
Shares outstanding 140.26M · Float 120.85M · 86.2% free float
Institutions13F, as of Jun 30, 2026
32 holders · 80.25M shares · 5 new positions · 11 increased · 3 reduced · 7 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Nantahala Capital Management, LLC | 68.39M | 48.76% | 0 | Aug 19, 2026 |
| Awm Investment Company, Inc. | 5.98M | 4.26% | 0 | Aug 14, 2026 |
| Vanguard Capital Management LLC | 2.01M | 1.44% | 0 | Aug 13, 2026 |
| Renaissance Technologies LLC | 935.1K | 0.67% | −52.3K | Aug 13, 2026 |
| Geode Capital Management, LLC | 517.1K | 0.37% | −12.1K | Aug 12, 2026 |
| Crescent Grove Advisors, LLC | 412.0K | 0.29% | 0 | Aug 10, 2026 |
| Nano Cap New Millennium Growth Fund L P | 400.0K | 0.29% | +50.0K | Aug 14, 2026 |
| Vanguard Fiduciary Trust Co | 258.0K | 0.18% | 0 | Aug 13, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Nantahala Capital Management, LLCincl. Harkey Wilmot B., Nantahala Capital Partners Limited Partnership +1 more | 49.10% | 68.39M | 13D | Aug 5, 2025 ↗ |
| Laurence W. Lytton | 6.80% | 9.46M | 13G | Apr 16, 2025 ↗ |
| Lytton Laurence W | 5.50% | 7.70M | 13G | Feb 17, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Stavros G. Vizirgianakis | director | 7.84M | 5.59% | Aug 18, 2026 |
| Sean E. Browne | director, officer: President and CEO | 3.11M | 2.22% | Aug 18, 2026 |
| Scott C. Neils | officer: CFO and Assistant Secretary | 1.22M | 0.87% | Aug 18, 2026 |
| John K. Bakewell | director | 1.13M | 0.81% | Aug 18, 2026 |
| Mark A. Schallenberger | officer: Chief Operating Officer | 1.11M | 0.79% | Aug 18, 2026 |
| Jonn R. Beeson | director | 733.1K | 0.52% | Aug 18, 2026 |
| Abhinav Jain | director | 373.7K | 0.27% | Aug 18, 2026 |
| Tyler Lipschultz | director | 373.7K | 0.27% | Aug 18, 2026 |
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.